CX Interviews
CX 2024: Focus on controversy-filled venous treatments
CX 2024 Executive Board member Stephen Black (London, United Kingdom) discusses his hopes and highlights of the upcoming venous programme at CX this year which is less than 1 week away! Get your CX [...]
CX 2024: Significant involvement from vascular trainees in this year’s vascular trauma programme
The vascular trauma programme at CX 2024 will involve vascular surgery trainees from across Europe, showcase data from the Vascular Interventions and Surgery in Trauma Audit (VISTA), and address controversy [...]
CX 2024: Don’t miss a series of great aortic debates by our world class faculty
CX 2024: An outstanding faculty will tee up timely debates to enhance vascular education Dittmar Böckler (Heidelberg, Germany), one of co-chairs of CX 2024, rings the CX bell, and calls out the fascinating programme lined [...]
CX 2024: Delivers on the complex and everyday issues in Vascular Access and Renal Interventions
Nick Inston (Birmingham, United Kingdom) and Kate Steiner (Stevenage, United Kingdom) members of the Vascular Access Executive Board promise CX 2024 will deliver not only the complex, the new, [...]
CX 2024: Aortic Programme forefronts cutting-edge edited cases “on film” and multiple top-notch debates
Tilo Kölbel (vascular surgeon from Hamburg, Germany, and a member of the Executive Board for the Aortic Programme) makes the case for moving images that will "easily transport" vascular surgeons and interventionalists. He also has his eye [...]
CX 2024: Brand new data on cyanoacrylate glue, bioprosthetic valves and intensive pulmonary embolism treatments
Manj Gohel (Cambridge, UK) and member of the Venous Executive Board parachutes straight into the CX Venous and Lymphatics Controversies Programme to highlight the VenaSeal SPECTRUM programme, SAVVE trial and SYNCHRONOUS trial, which [...]